Clinical Trials

Clinical trials contribute to advanced care

Clinical trials can improve quality of life for patients. At Riverside, we offer clinical studies in neurology, oncology, and cardiology. Our dedicated team of physicians and researchers is committed to providing a positive experience for all clinical trial participants. Our primary concern is the health and safety of our patients.

New clinical trials are available.

View All Clinical Trials

BMS CA209-7A8

New

BMS CA209-7A8: A randomized, non-comparative neoadjuvant phase II study in patients with ER+/HER2- breast cancer >2 cm with safety run-in, assessing nivolumab + palbociclib + anastrazole (Checkmate 7A8)

Status Recruiting
Category Oncology

Celgene ACE-536-MDS-002

New

Celgene ACE-536-MDS-002: A phase 3, open-label, randomized study to compare the efficacy and safety of Luspatercept (ACE-536) versus Epoetin Alfa for the treatment of anemia due to IPSS-R very low, low or intermediate risk myelodysplastic syndromes (MDS) in ESA naive subjects who require red blood cell transfusions. (COMMANDS)

Status Recruiting
Category Oncology

SMX18-001

New

SMX18-001: An open-label, randomized, multicenter study evaluating the activity of lasofoxifene relative to fulvestrant for the treatment of Pre- and Post-Menopausal women with locally advanced or metastatic ER+/HER2- breast cancer with an ESR1 mutation. (ELAINE)

Status Recruiting
Category Oncology
meet the clinical trials team

Clinical Trials

Meet the Research Team

Our researchers (Principal Investigators and Study Coordinators) bring over 150 years of experience conducting Phase II, III and IV drug and device trials.

Our Research Team